Related Party Transactions - Additional Information (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Feb. 28, 2026 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Related Party Transaction [Line Items] | |||||
| Related party transaction, amounts of transaction | $ 0 | ||||
| Common Warrants | 238,931 | 424,033 | 238,931 | ||
| Cash proceeds from warrants | $ 3,000,000 | $ 5,600,000 | |||
| Proceeds from exercise of warrants | $ 3,000,000 | $ 3,010,000 | $ 0 | $ 5,702,000 | $ 0 |
| Exercise price | $ 12.6 | ||||
| Minimum | |||||
| Related Party Transaction [Line Items] | |||||
| Percentage of beneficial ownership of capital | 10.00% | 10.00% | |||
| X | ||||||||||
- Definition Percentage of beneficial ownership of capital. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of transactions with related party during the financial reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|